Evidence map›Paper›PMID 35256024›Full record

ArticleBJPsych open2022

The prevalence, incidence, prognosis and risk factors for symptoms of depression and anxiety in a UK cohort during the COVID-19 pandemic.

Ru Jia, Kieran Ayling, Trudie Chalder, Adam Massey, Norina Gasteiger, Elizabeth Broadbent, Carol Coupland, Kavita Vedhara

Open access · goldAbstract read
In one paragraph

Article in BJPsych open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Suicidal ideation among young adults in Canada during the COVID-19 pandemic: evidence from a population-based cross-sectional study.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ru JiaCentre for Academic Primary Care, School of Medicine, University of Nottingham, UK.ORCID https://orcid.org/0000-0001-6843-8250
Kieran AylingCentre for Academic Primary Care, School of Medicine, University of Nottingham, UK.
Trudie ChalderDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.ORCID https://orcid.org/0000-0003-0775-1045
Adam MasseyCentre for Academic Primary Care, School of Medicine, University of Nottingham, UK.
Norina GasteigerDepartment of Psychological Medicine, University of Auckland, New Zealand.
Elizabeth BroadbentDepartment of Psychological Medicine, University of Auckland, New Zealand.
Carol CouplandCentre for Academic Primary Care, School of Medicine, University of Nottingham, UK.
Kavita VedharaCentre for Academic Primary Care, School of Medicine, University of Nottingham, UK.
University of Nottingham · GBUniversity of Auckland · NZKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has had profound consequences for population mental health. However, it is less clear for whom these effects are sustained.

aimsTo investigate the prevalence, incidence, prognosis and risk factors for symptoms of depression and anxiety in a UK cohort over three distinct periods in the pandemic in 2020.

methodAn online survey was completed by a UK community cohort at three points (n = 3097 at baseline, n = 878 completed all surveys): April (baseline), July to September (time point 2) and November to December (time point 3). Participants completed validated measures of depression and anxiety on each occasion, and we prospectively explored the role of sociodemographic and psychological factors (loneliness, positive mood and perceived risk of and worry about COVID-19) as risk factors.

resultsDepression (Patient Health Questionnaire-9 means: baseline, 7.69; time point 2, 5.53; time point 3, 6.06) and anxiety scores (Generalised Anxiety Disorder-7 means: baseline, 6.59; time point 2, 4.60; time point 3, 4.98) were considerably greater than pre-pandemic population norms at all time points. Women reported greater depression and anxiety symptoms than men. Younger age, history of mental health disorder, more COVID-19-related negative life events, greater loneliness and lower positive mood at baseline were all significant predictors of poorer mental health at time point 3.

conclusionsThe negative impact of the COVID-19 pandemic on mental health has persisted to some degree. Younger people and individuals with prior mental health disorders are at greatest risk. Easing of restrictions and resumption of social interaction could mitigate the risk factors of loneliness and positive mood.

Indexed as

anxietyCOVID-19depressionMental healthrisk factors

Identifiers

PMID35256024
PMCPMC8914134
OpenAlexW4220685402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.